Strain WD, Frenkel O, James MA, Leiter LA, Rasmussen S, Rothwell PM, et al
(2) normal temperature plus exogenous GSH treatment (NT+GSH): added 0.25 mM GSH in nutrient solution one day before the treatments and maintained at 0.25 mM GSH in the nutrient solution during the treatment period
GLP-1 neuronal circuits in hypothalamic appetite regulation and food reward processing Metabolic surgery pharmacology : Studying whether pharmacological dual incretin agonism can replicate the hormonal changes and metabolic benefits of bariatric surgery Cardiovascular research : Elucidating mechanisms of cardiovascular risk reduction via combined GIP/GLP-1 receptor activation NASH/MAFLD research : Exploring effects on hepatic steatosis, inflammation, and fibrosis (SYNERGY-NASH trial ongoing) Peptide engineering : Studying multi-target receptor agonism as a design paradigm how to engineer selectivity ratios across receptor families Comparative pharmacology : Benchmarking dual (GIP/GLP-1) vs
For some people, those factors outweigh the efficacy gap
Wright, MD, PhD , can be reached at [email protected].
Cost-reduction options include manufacturer savings cards (typically reducing copay to $025/month for insured patients), GoodRx discount codes, and licensed Canadian pharmacies, which often offer the same brand-name medications at significantly lower prices